Phase II clinical study of SH/TA-508, at ultrasound contrast agent: A dose-finding study of SH/TA-508 in color Doppler flow imaging in the kidneyHirohíde Matsuo, H Sawada, Takafumi Yura et al.|Unknown|1995Cited by 1